Gene · 1196
Papers648
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 648
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative multi-omics analysis identifies histone methyltransferase SUV420H2 as a prognostic biomarker in clear cell renal cell carcinoma. | Discov Oncol | 2026 | 42449034 | PubTator, text mining | PubMed |
| Integrative phosphoproteomic analysis identifies functional roles of TRPM7 phosphosites in oncogenesis. | Front Bioinform | 2026 | 42305666 | PubTator, text mining | PubMed |
| A risk stratification framework based on ammonia-induced cell death signatures for prognostic assessment and therapeutic insights in colorectal cancer. | Discov Oncol | 2026 | 42223795 | PubTator, text mining | PubMed |
| Whole exome sequencing reveals rare DNA repair gene variants in BRCA1/2-negative Arab early-onset breast cancer patients. | Sci Rep | 2026 | 42098349 | PubTator, text mining | PubMed |
| Integrated network toxicology and multi-omics analysis reveals Benzo(a)pyrene-driven molecular networks and prognostic biomarkers in colon cancer. | Int J Environ Health Res | 2026 | 42017488 | PubTator, text mining | PubMed |
| Brain Permeable SGK1 Inhibitors: A Promising Therapeutic Strategy for Neurodegenerative Diseases. | J Med Chem | 2026 | 41837733 | PubTator, text mining | PubMed |
| Systematic Examination of Gene Expression and Proteomic Evidence Across Tissues Supports the Role of Mitochondrial Dysregulation in ME/CFS. | Int J Mol Sci | 2026 | 41752134 | PubTator, text mining | PubMed |
| CLK1 is a potential tumor suppressor for NSCLC by regulating cell proliferation and immune infiltration. | Front Cell Dev Biol | 2026 | 41737282 | PubTator, text mining | PubMed |
| Decoding SR protein regulation: kinases, phosphatases, and therapeutic targeting strategies. | Cell Oncol (Dordr) | 2026 | 41636961 | PubTator, text mining | PubMed |
| White Rabbit in radio interferometry. | Exp Astron (Dordr) | 2026 | 41492437 | PubTator, text mining | PubMed |
| Fibroblast growth factor receptor inhibitors in glioma: a narrative review of recent advances. | Front Pharmacol | 2025 | 41567627 | PubTator, text mining | PubMed |
| Research towards selective inhibition of the CLK3 kinase. | Beilstein J Org Chem | 2025 | 41158282 | PubTator, text mining | PubMed |
| Unveiling molecular moieties through hierarchical Grad-CAM graph explainability. | BMC Bioinformatics | 2025 | 41131466 | PubTator, text mining | PubMed |
| CLK2 Regulates the KEAP1/NRF2 and p53 Pathways to Suppress Ferroptosis in Colorectal Cancer. | Cancer Res | 2025 | 40882016 | PubTator, text mining | PubMed |
| A 28 mK Resolution, -0.45 °C/+0.51 °C Inaccuracy Temperature Sensor Using Dual-Comparator Architecture and Logic-Controlled Counting Method. | Micromachines (Basel) | 2025 | 40872454 | PubTator, text mining | PubMed |
| Biomolecular phase separation in tumorigenesis: from aberrant condensates to therapeutic vulnerabilities. | Mol Cancer | 2025 | 40849651 | PubTator, text mining | PubMed |
| Targeted therapy for knee osteoarthritis: From basic to clinics. | Medicine (Baltimore) | 2025 | 40826764 | PubTator, text mining | PubMed |
| RNA Epigenetics in Cancer: Current Knowledge and Therapeutic Implications. | MedComm (2020) | 2025 | 40761481 | PubTator, text mining | PubMed |
| Targeting HASPIN kinase disrupts SR protein-mediated RNA splicing and synergizes with BCL-2 inhibitor venetoclax in AML. | Blood Neoplasia | 2025 | 40735352 | PubTator, text mining | PubMed |
| Pharmacological CLK inhibition disrupts SR protein function and RNA splicing blocking cell growth and migration in TNBC. | Breast Cancer Res | 2025 | 40731028 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1196/papers